BPC-157
Also known as: Body Protection Compound 157, pentadecapeptide BPC-157
Preclinical and limited clinical literature on BPC-157, a synthetic pentadecapeptide studied in wound healing and GI models.
What does the research say about BPC-157?
BPC-157 appears primarily in rodent wound-healing, tendon, and GI injury models. Human evidence remains sparse; Synapse surfaces indexed papers and active investigators for transparent literature review.
Synapse surfaces peer-reviewed research and researcher networks for informational purposes only. This page does not provide medical advice, dosing guidance, or treatment recommendations.
Research feed: BPC-157
11 indexed papers matched to curated MeSH concepts in the last 90 days.
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of SevereElectrolyte Disturbances in Rats
This review explores BPC 157's effectiveness in managing electrolyte imbalances in rats, highlighting its therapeutic potential.
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase
Randomized trial investigates BPC-157 and its analogs' inhibitory effects on acetylcholinesterase, indicating potential for neurodegenerative therapies.
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management
Preclinical research explores BPC-157's effects on tissue healing and pain relief, indicating therapeutic promise.
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats—A Cytoprotection Approach
Randomized trial investigates BPC 157's cytoprotective effects post adrenalectomy in rats, suggesting therapeutic potential.
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
Randomized trial evaluates BPC 157's protective effects in lower limb ischemia-reperfusion injury in rats, suggesting therapeutic potential.
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Narrative review evaluates BPC-157's formulation, pharmacokinetics, and development barriers in therapeutics, indicating critical gaps.
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics
Review demonstrates that cytoprotection reduces hemorrhage and thrombosis in rodent models, indicating BPC 157's promise for wound healing.
Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery
Experimental results reveal BPC 157 reduces vascular tone in human arteries, suggesting its endothelial NO-mediated vasorelaxant potential.
Down Regulation of HPV 16 and NF-KB with APG-157 in Head and Neck Cancer
Phase 2A clinical trial evaluates APG-157's effect on HPV 16 and immune markers in head and neck cancer, suggesting therapeutic potential.
Research Peptides for Sale: Quality Standards for BPC-157, TB-500, Sermorelin and Epitalon Procurement
Technical review outlines quality verification standards for research peptides, suggesting improved procurement processes.
Researchers studying BPC-157
Researcher network data is loading or unavailable for this topic.
Follow BPC-157 literature with AI-enriched clinical evidence on Synapse.
Search BPC-157 on SynapsePowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers